{"ok":true,"article":{"slug":"regeneron-s-pasatru-scores-fda-approval-in-ultrarare-bone-lesions-disorder-e3e86c6f","title":"Regeneron's Pasatru scores FDA approval in ultrarare bone lesions disorder","url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE15bmQ5M0s5MFdmeEJ0UHhJM09rcVFkX2hfMDM3ZTVBSmJ1akplNm8xRC1hV3BXNDJGRVAwVi1lcjFjQ0MycTBQYkZLMGRLSEVtVFNVUmxjWUtFZjJpc2NvejlKdVBqTEdYZ2c?oc=5&hl=en-US&gl=US&ceid=US:en","canonical":"https://www.aimode.news/article/regeneron-s-pasatru-scores-fda-approval-in-ultrarare-bone-lesions-disorder-e3e86c6f","sourceName":"Fierce Pharma","summary":"Related coverage: Regeneron's Pasatru scores FDA approval in ultrarare bone lesions disorder Fierce Pharma","category":"Health","image":null,"lang":"en","publishedAt":"2026-08-19T18:35:17+00:00","createdAt":"2026-08-19T19:00:19.683789+00:00"}}